Mankind Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 24, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019
Market Capitalization	1,166,167	921,654	-	-	-	-	Upgrade
Enterprise Value	1,125,966	902,241	-	-	-	-	Upgrade
Last Close Price	2910.60	2300.75	-	-	-	-	Upgrade
PE Ratio	55.23	48.18	-	-	-	-	Upgrade
Forward PE	51.62	43.88	-	-	-	-	Upgrade
PS Ratio	10.58	8.92	-	-	-	-	Upgrade
PB Ratio	11.04	9.62	-	-	-	-	Upgrade
P/TBV Ratio	11.32	12.00	-	-	-	-	Upgrade
P/FCF Ratio	58.33	50.17	-	-	-	-	Upgrade
P/OCF Ratio	43.48	42.82	-	-	-	-	Upgrade
PEG Ratio	3.14	1.91	-	-	-	-	Upgrade
EV/Sales Ratio	10.22	8.73	-	-	-	-	Upgrade
EV/EBITDA Ratio	39.72	35.57	-	-	-	-	Upgrade
EV/EBIT Ratio	46.62	41.93	-	-	-	-	Upgrade
EV/FCF Ratio	56.32	49.11	-	-	-	-	Upgrade
Debt / Equity Ratio	0.04	0.02	0.02	0.14	0.06	0.04	Upgrade
Debt / EBITDA Ratio	0.17	0.08	0.09	0.44	0.16	0.09	Upgrade
Debt / FCF Ratio	0.24	0.11	0.17	1.94	0.34	0.16	Upgrade
Asset Turnover	0.88	0.95	0.93	1.00	1.09	1.28	Upgrade
Inventory Turnover	2.09	2.18	1.84	1.69	1.77	2.23	Upgrade
Quick Ratio	2.07	2.02	1.14	0.65	1.78	1.32	Upgrade
Current Ratio	2.95	3.10	2.32	1.68	2.89	2.26	Upgrade
Return on Equity (ROE)	22.02%	22.58%	18.79%	25.99%	30.30%	31.75%	Upgrade
Return on Assets (ROA)	11.97%	12.41%	10.52%	14.76%	17.37%	20.01%	Upgrade
Return on Capital (ROIC)	14.95%	15.30%	13.24%	18.56%	22.22%	26.05%	Upgrade
Earnings Yield	1.81%	2.08%	-	-	-	-	Upgrade
FCF Yield	1.71%	1.99%	-	-	-	-	Upgrade
Payout Ratio	0.00%	-	-	-	-	29.35%	Upgrade
Buyback Yield / Dilution	-0.11%	-0.14%	-0.00%	-	-	-	Upgrade
Total Shareholder Return	-0.11%	-0.14%	-0.00%	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.